ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000539.1|Nukacin_1 # 2 # 178 # -1 # ID=1_1;partial=10;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.282	BGC0000539.1|Nukacin_1 	2	178	-	Loose	1000	21.557	Clostridium perfringens mprF	69.23	3003773	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	GTGAATTCAACTGGATTATTTAATCTGGTTCTATTACAAAAAATTAAAGTTTTAGAAAATTCAGATATAACGTTATATTGTATTTTGAAAACAACTTATAATCTAGTTCCCCCATCTCCTTTACAAGAGATGGGGGGGGAACATTTGATTTTTTGTTCAAAGTTTAAAGATAAAGCT	MNSTGLFNLVLLQKIKVLENSDITLYCILKTTYNLVPPSPLQEMGGEHLIFCSKFKDKA	MWDSLKKSYRHLKNILGFVTDKRNYENIKKLLKNYKILSDISNIIVSVLVFLSGILLIISGIYPSIFYKIKFLDNIYSLSFLRFSHRASILIGLMLIMTSKEVFFKVKRAYYVTLTLLIVGGAFAFIKDLDYKEGIFILGVIILLILSKKSFYRKSIPIKVTKLSGILIVLSIVMIIFASFIHKFNIHFSKNYKYYIDFFHSTKGYLRIALFTYISFIIFVIIWYLTMPKIEDDERYMDADLEKVSKFFKEIDYGTIFSHLVYLKDKKVFWANEGESLIMYSKYKDKIIVLGDPIATKENLYSCIEEFQAFTNLYGYDVVFYEIEEKNFSTYHDAGYYFFKLGEEARIDLEEFNLIGSKKSAFRNTLRRVEREGYNFSIIEPPFNNEVVSQLKEISDKWLGDRKEKGFSLGWFSEDYIQRSPIAILKNEEENKIMGFVTIMDANDGGETVAIDLMRIDKDAPNASMDYLMLNLFLTFKEKGYKYFSLGEAPLSNVGFNTHSHLQEKLARLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYLAYPKFMSLPEVFINLCLLIANSKERVEKK	10.37	gnl|BL_ORD_ID|2058|hsp_num:0	2282			822	861	defensin
BGC0000539.1|Nukacin_2 # 156 # 899 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.247	BGC0000539.1|Nukacin_2 	156	899	-	Loose	400	28.8758	vanR gene in vanA cluster	24.19	3002919	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGAAAAAAATAAATGCTATTATTATAGACGATAATGCAAGTACTAGAGAGGATTTAAAAGTAAATCTATCTTACTTCTCATTTGTTTCATGTAAAGGTACATTTAGTGAATATATTGAAGCCAAAAATACCCTAGATAAGAAAGATATAGACTTAATATTTTTAAAAATAAATACAAATAACAACAAGTTTATAGATATAGCCAATAATATCAATTCTATACATAAACATATTCAAATAGTTTTTCTATCTTCTGATTCCAAACACGCACATAAAAGTTTTGAAGCTCATCCTTTTGACTATTTAATACAACCAGTAGAGCCTATTAAATTGGAGAAGTGCTTACTTCATTTCAAAAATAGATGCAGAAAAAAATTCGATCTTAACAATCTTAAAAACAGAAAAATCGCCATTAAAAAGGGGAAATCTTTATATTTTTTAGAAATTGATAAAATTACAACAGCAGAATGTTGCGGTAGAAAAATAATTATCACTTTGGATGACAAAGAAACAGTTTCTTATAATGGCTCCTTAAAATATTTAGAAAAAAAACTCTATTCTTATGGATTTATTTTAGTAAGTAGGTCATTACTTATTCCTTTAAAAAGTATTAAAAATATAATATTCGATAAGCATAGTAAATGCTATATTTTGAAATCGATTAAGAATAATACGGTTAAAATCACTCCAGAAAAGTATAAAAAAGTAAAGCAAACATTAAGTGAATTCAACTGGATTATTTAA	MKKINAIIIDDNASTREDLKVNLSYFSFVSCKGTFSEYIEAKNTLDKKDIDLIFLKINTNNNKFIDIANNINSIHKHIQIVFLSSDSKHAHKSFEAHPFDYLIQPVEPIKLEKCLLHFKNRCRKKFDLNNLKNRKIAIKKGKSLYFLEIDKITTAECCGRKIIITLDDKETVSYNGSLKYLEKKLYSYGFILVSRSLLIPLKSIKNIIFDKHSKCYILKSIKNNTVKITPEKYKKVKQTLSEFNWII	MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTSGLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRYKKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSELLFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK	106.93	gnl|BL_ORD_ID|750|hsp_num:0	722			75	414	vancomycin; teicoplanin
BGC0000539.1|Nukacin_3 # 1326 # 1499 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.322	BGC0000539.1|Nukacin_3 	1326	1499	-	Loose	200	21.557	vanT gene in vanE cluster	33.33	3002971	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGGAAAATTCTAAAGTTATGAAGGACATTGAAGTAGCAAATTTATTAGAAGAGGTTCAAGAAGATGAATTGAATGAAGTCTTAGGAGCTAAGAAAAAGTCAGGAGTAATCCCAACTGTGTCACACGATTGCCATATGAATTCTTTCCAATTTGTATTTACTTGTTGTTCATAA	MENSKVMKDIEVANLLEEVQEDELNEVLGAKKKSGVIPTVSHDCHMNSFQFVFTCCS	MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN	8.12	gnl|BL_ORD_ID|4680|hsp_num:0	1308			1284	1380	vancomycin
BGC0000539.1|Nukacin_4 # 1901 # 4654 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.254	BGC0000539.1|Nukacin_4 	1901	4654	+	Loose	500	27.335	almG	25.97	3004364	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	lipid A acyltransferase; polymyxin resistance operon	ATGAACAACATTAAAGTTGAACAATTTAGAGGATTTTCAAATTTTATTTTAAAAAAATACTCTAAACAAGAACTTAACACATTAATTGATTGGAACTACTTAAGATCTATTATTCTAGATATTTGTGGAAAATCATTGATTGTTTTAATTAATGAAAAAAGATTAAACAAAAAACTCAATGGAAATACTCCTGAAGAACGCTATAAATATTTTGATGAAGAATTATGTGAAAAAGGGATTATATATGAAGAGTTAAATAAAAGTTATCCATCAATAATAAATGATTTAGAGCAAACTTTAAACTCATATTTTTCGTTTTTGAAAGAAATCGAAAATAAATTCAATCAAGAAAAAAAGAAACTTTTAGAAGCCAATTTAATAAAAACTGAAAAAGAAACGATTTGTCATATCAGTATTTTAGGAGATTTACATGGAGGTAAAGCGGTGACTAAAGTAACCACTGATAAATCTCAATTATTATATAAACCTAGGTCATTAGAAAATGATAGTTTCTTTTTAGAATTCTTAGAATTTATGTACAGTTTTCAAAAAAATGAAATATCAACATACTATAAGTATAAATTCATAGATTATAAAGACCACGGTTGGATGGAATATATAGAAAAGCAACCTACCTCTAAAAATAAAATAAATATGTATTACAAAAGATTGGGATATTTATTGTCTATAGGATATTTATTAAATATAAGTGATTTACATTTCGAAAATATACTGTGTTCCAGTAATTTTCCAATATTAATTGATTTAGAAACTATATTTCATACGTCCATATATGAATCAAAATTTCGTAATTTAGCTACAAAGAATATAGAAGATAAAGCTGCTAATTCTGTATTCGCTACCGGAATGTTACCGATATCCAAAAAAGACAAAAAATACGGTGGAGATATAAGTGGAATATTAGGTGGAGTATTTAATAAACACGAAAGAACTATAAGTAATCCTAATAGAGATGATATAAAATTCGAAAAGAGATTAGTAAGAGTTAAAAGAAATGATCATATCCCATTTTATATGGAAAATGATAAAAAAAGGAGATTTTCTCCCGAAGTATTTATAGAAGATATTCAAGAAGGCTTTAAATATGGTTACGAATTATTTCTTAACAATAGAAAAGAAATACTACATTATATAAAGAAAACGTCATCAGAAGTAGAAGTGAGAATTTTACCAAGAAGTACAATTGAGTACTCAGTATTAATACAAGCTGCTAAATCACCTCTTTATGCAAATAAGCGAAAGAGCTTGTTTAACAAACTAGAAGAGTACGGTGAAAATTTATTAAGTGATAAGTTAATAAATTCAGAAATAAAACAAATAGAAACTCTTTCAGTACCCTATTTTTATACTAAGGTCCAAAGTGTTTCGGTAAAAGATATTAAAAATAATACGGTACATCACTTATTGAAAAACCCACTCAATGTATTTTTAGAAAAAACGCAAAGATATTCTTTGAAAGATTTGTTGTTTCAATGTAAACTAATAAAATTTTCATTAGAAAGTCAAAATAAATTATTTATTGATGGTAATGGATTTATAAATTATGAATATGAAATAGTAAATTCAGACAATATTGACGATGCAATCGACAATTTAGTAAGCATTATAATTAATAATGCAGTCATAGATGAAAAAGATGGTTCTGTAAATTGGATGAATTTAGGCATATCAAAAGAAGAAGAAATAATATTTGAAAGCTTGTCAGATGACTTATATAAAGGATTGTCAGGAATAGGAATAGCTTTATTAAAATATTATGAAATTAACAAAAACTTAAAAGATATGAGTAGACTAAAAAAAATACTAAGCAGTATTTATTCTTCTATATTAAGTAATATAAATACTAATTCTAGTAAAGAAAAGGATTTATCTTTTTTTAATGGTGAAATAGGTAAAATCGCATTTTTATATAAATACCAGATTGAATTTAAAGAAAATTGCGACAGCAGTAAAAATTATATGAAACATATTTTAGGGATCATTTTATCTAGTGAATTTGAAATGAATGACATTATAGCCGGATTACCAGGAATTATTTCATATTTATATAATCAAGAAATATTTTCTAAAGAACTTGTAATAATGGGAGATAGACTATTAAAAGACTTAGACAATAATCCAACTATGGCTAGCTACGCTCACGGTAAAAGTGGGGTAATGGTTTCATTATTATATTTATATGATTTAACTAAAGACAAAAAGTATCTAGTTAAATTCCATCAGGAATGGAAAAAAGAAAACACATTAAAATTGGAAATAGGATGGAAAGATGTAAGACAAAATGAAGAAACCTACTCTGTATCATGGTGTAACGGAGTTACAGGACAGTTAATAAGTAGACTAGTTGCTTTAGAAATTCATGATAAAGTAAAAATATTTGATGCTGTAAATAAAAAGTTAATGCAAAAAGAAATTGAAGAATTACTTTATTTATTGAAAGAAGAAGGATTAGAACAAAATAATTTTTGCCTATGTCATGGCGTCATGGGAAATTTACTGGTTTTAAATTACTATCAAAAAAAATTTGAAAATACAAACATTCATTTAGCCAATAAAATAGACAGTCATTTTTATTCAGTAGCTAATTTTGGTTTAAATAAAGGATGGATATGTGGCTTAGGAAATAACTTTTACTCTTTTAGCATTATGACAGGAATATCAGGTATTTTATATGCTTTTTTAAAGTATAAAACTAAGGATACTGAATTAGGTATATTGTTACCAAACATTTAG	MNNIKVEQFRGFSNFILKKYSKQELNTLIDWNYLRSIILDICGKSLIVLINEKRLNKKLNGNTPEERYKYFDEELCEKGIIYEELNKSYPSIINDLEQTLNSYFSFLKEIENKFNQEKKKLLEANLIKTEKETICHISILGDLHGGKAVTKVTTDKSQLLYKPRSLENDSFFLEFLEFMYSFQKNEISTYYKYKFIDYKDHGWMEYIEKQPTSKNKINMYYKRLGYLLSIGYLLNISDLHFENILCSSNFPILIDLETIFHTSIYESKFRNLATKNIEDKAANSVFATGMLPISKKDKKYGGDISGILGGVFNKHERTISNPNRDDIKFEKRLVRVKRNDHIPFYMENDKKRRFSPEVFIEDIQEGFKYGYELFLNNRKEILHYIKKTSSEVEVRILPRSTIEYSVLIQAAKSPLYANKRKSLFNKLEEYGENLLSDKLINSEIKQIETLSVPYFYTKVQSVSVKDIKNNTVHHLLKNPLNVFLEKTQRYSLKDLLFQCKLIKFSLESQNKLFIDGNGFINYEYEIVNSDNIDDAIDNLVSIIINNAVIDEKDGSVNWMNLGISKEEEIIFESLSDDLYKGLSGIGIALLKYYEINKNLKDMSRLKKILSSIYSSILSNINTNSSKEKDLSFFNGEIGKIAFLYKYQIEFKENCDSSKNYMKHILGIILSSEFEMNDIIAGLPGIISYLYNQEIFSKELVIMGDRLLKDLDNNPTMASYAHGKSGVMVSLLYLYDLTKDKKYLVKFHQEWKKENTLKLEIGWKDVRQNEETYSVSWCNGVTGQLISRLVALEIHDKVKIFDAVNKKLMQKEIEELLYLLKEEGLEQNNFCLCHGVMGNLLVLNYYQKKFENTNIHLANKIDSHFYSVANFGLNKGWICGLGNNFYSFSIMTGISGILYAFLKYKTKDTELGILLPNI	MRIFWLKALTSGLFYLPLSIKNGLCRLVAKPISRKKMAAALTQLNYALPDLGDVKKQAIVEQSTRLSLKNLLGFCHLKRYQYQVEQPDLVQEILDNQGGGIIVCPHMGVYDGVTWWLNQQGKKAVTIFGAGSSGDRPDENAMISQAAKLAGVPYLLRKQNLMLELAQRIKQGEWVVLHTDMRTEGVPVRWFGQATQLSATPFFLAHKLACPIYFHYALSEGMTQRLHFSRFALHQTDDLSRNIAQDAQQLADMMQQAITAHPEQWIWLYRRFK	335.90	gnl|BL_ORD_ID|2487|hsp_num:0	2878			177	354	colistin A; colistin B
BGC0000539.1|Nukacin_5 # 4676 # 6760 # 1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.252	BGC0000539.1|Nukacin_5 	4676	6760	+	Loose	1100	126.331	tetA(60)	26.53	3004035	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTGAAAATCGCATTACAAAATAGTGACCAAGACTGTCTATTAGCGTGTTATTCAATGATTTTGAGTTATTTTGGTAAAAATGTATCTATAAATAGTCTTTACAAAAGAGAGATGATACCACCTGATGGTCTATCAATATCTTATTTGAAAGAATTAAATATTAAGTACGAACTTAATATGAAAGTATATAGAATTAAAGATAAAGAAAAAACATTCCGAGTAATAAGTAAAATAAAGAAACCAATAATTGTTCATTGGGATTTAAATCATTTTGTCATAGTAAAAAACGTTAAAAAAAAACATATAGAAATAGTCAACCCAGAGATAGGAAAAGTAAAAATTTCAAAAGAGATGTTTTTGGAACATTTTTCAAATGTTCTATTAATGTTTGATCCTAAGAGCGATTTTACAAAAGATAAAGAAAAAATTGAGTTCTTTGACGATTTAAAAAGTGTTTTAATGAATAAAAACATAATTCTTTTTTCATTTTCAGTGATGTTAGCTCAAATTGTAGCTCTAATTTTTTCAATAGTTGTTAGAGATATAATAAATCAAAAATATACATACCTAATATCATTATCAATGCTATTAATGATGATTATTATTCAAATATTTTCTTTAGTTTTTAAGCAAAAAGCTCAAATTAAAGAGAATAAAATATATGAAAAAATCATTTCCTATAACATGTTTGAAGGATTATTTAACAAGCCCTTATTATACTTTAGAAATAGCACAATAGGTACTTTGATGGAAAAGATAAATATAAAGACTACTATAAGGGACAACATACTGCTTAAAATATTGCCATCATTCTTAAACTTCTTTTCCGTTACGGTATTGTTTATATATTTGTTAACTGTATCACTGCTATTATCATTATTACTTTTAGGTATGTCCATTATATATTTGTTAATCAGTGTGTTTATATATATAAAGAAAAATCAATTGAATATTGAGTATATGCAGAGAACTATACAATTTAGTTCTTTAGCTCAAGAATCATTAAGTCAAATTGATCAAATTAAGGCCCAAGCTCAAGAATCATCAACAATAAATAACTGGAAAGAAAAAAGTTGGAATATAGTTAACTCTTATAATTCAATTTTGAAAATTGAAGGATTATCATATACTTTTAATCAAATTTTCAATTACAGTAGCATAATACTTTTAATGATTTTTGGTATTCATCTTACAAAATACGGAAATATAACCATAGCAGATTTAATCTTATTTCAATCCGGTATGTCTATATTTAGTTCATCTGTTTCACAACTACAAGACATTACGTTTGAAATATCAAAAATTAAAGTGTCCGGCGAGAAAATCAATGACTTATTTTTAAAAAATAATACTAAAAGAAAAGTAATCGAGCAGAAATCTAATAATGCTTTATCACTTAAGAATGTTACTTTTGGTTTTGATGAAAAAGCCCCTATATTGAAAAACATTACTTTCCAAGTAAAAAAAGGTGAAAAAGTAGCTATAGTAGGAGACTCCGGATCAGGTAAAAGTACTATGTTAAATGTTCTGTTAGGTCTCTATACATGTGATGGTGAAGTAGTTTACGGTTATAGAGATTTTAGGAAAATAACAGGGGTCGTCTTACAGAATATGACGTTAAGTAAACAATCTATTTATAATAATTTGGTGGATGAAGGAAATGATAGCAATATGCAAAAATTAAACCAAATACTATACGATGTTAATATTATAAACTTGATAAATTCTTTACCTAATAAAATATATTCTAGTGTATTTCAAAATGGAAAAAATCTATCTGGTGGTCAAATTCAAAGGCTATTAATTGCTAAATCTCTATTTAATAAAAAATTAATTTTTTGGGATGAAGCTTTTAGCAGTTTGGACAATTACAATCGTATAAATATATATAGAAATGTTTTGAAAAATAGTCAATATAGCGATAAAACTATAGTACTCATAAGTCACCATCTAGATGTTTTATCATATGTCGACAAAGTAATGTTTATTGAAAACGGAAACGCTTTTTTTGGAACACATAATGAATTAATTAAAAATAATAAAAATTATAGAAGATTCTTAGATACTGCCAATACTAATAATTAA	MKIALQNSDQDCLLACYSMILSYFGKNVSINSLYKREMIPPDGLSISYLKELNIKYELNMKVYRIKDKEKTFRVISKIKKPIIVHWDLNHFVIVKNVKKKHIEIVNPEIGKVKISKEMFLEHFSNVLLMFDPKSDFTKDKEKIEFFDDLKSVLMNKNIILFSFSVMLAQIVALIFSIVVRDIINQKYTYLISLSMLLMMIIIQIFSLVFKQKAQIKENKIYEKIISYNMFEGLFNKPLLYFRNSTIGTLMEKINIKTTIRDNILLKILPSFLNFFSVTVLFIYLLTVSLLLSLLLLGMSIIYLLISVFIYIKKNQLNIEYMQRTIQFSSLAQESLSQIDQIKAQAQESSTINNWKEKSWNIVNSYNSILKIEGLSYTFNQIFNYSSIILLMIFGIHLTKYGNITIADLILFQSGMSIFSSSVSQLQDITFEISKIKVSGEKINDLFLKNNTKRKVIEQKSNNALSLKNVTFGFDEKAPILKNITFQVKKGEKVAIVGDSGSGKSTMLNVLLGLYTCDGEVVYGYRDFRKITGVVLQNMTLSKQSIYNNLVDEGNDSNMQKLNQILYDVNIINLINSLPNKIYSSVFQNGKNLSGGQIQRLLIAKSLFNKKLIFWDEAFSSLDNYNRINIYRNVLKNSQYSDKTIVLISHHLDVLSYVDKVMFIENGNAFFGTHNELIKNNKNYRRFLDTANTNN	MNDLLKVIINFIKKHPMRYLVSFILMIGSSIAAVYPARIIGQVVDKIVASELNAEWLGTQLVILVGIILVAYITESIWTYFIFIGYYEIQKELRVKLLRNNLRKKIPFYAHFRTGEIITRSSEDVTTIGDMMGFGMFALMNSTLLMSVSIYMMVTTISLPLTIAAILPLPILSYLVYKWGFDLEEEYNKAQNAVSQLNNEVLEMIDGTYVIRAYGQEDAMMDEFRAKTKKAMKQNIIVTEIESRFIPLAQLFMMISFTIALFYGGYLVSTGAILVGDVIAFQVYMGAIMWPMFMIGDIITNYKRGKVATERINEVLKHDDEIERGGTKTLETIESIEFKDFHFMYPGEEAPLLKEINLTLRKGETLGIVGKTGSGKTTLLMQLLHQFPYRGEKLLINGEPLIDYDTQSVAGHLAYVPQEHTLFSRTIRENMLFGKEDATDDEIWEALTLASFEGDVKRMPDELDTMVGEKGVSLSGGQKQRLSIARAFLRNRECLILDDALSAVDAKTEREIISHLQQERGGCMNIISAHRLSAIRHADEIIVMNEGRISERGTHEELLEQRGWYYEQYLTQEMEEEIE	119.86	gnl|BL_ORD_ID|2310|hsp_num:0	2645			447	1695	tetracycline
BGC0000539.1|Nukacin_6 # 6773 # 7648 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.269	BGC0000539.1|Nukacin_6 	6773	7648	+	Loose	570	228.409	bcrA	50.67	3002987	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGATTAACAATATTGTACAAACCCAAAATTTAACAAAAAAGTTTTCAGATAGTTATTCAGTAGACAATCTATCACTAAATATTGGTTCGAAAGAAATATATGGATTTTTAGGTCCAAATGGTGCTGGTAAAAGTACTACAATGAAAATGTTACTAGGTCTCATGCAACCAACTAAAGGTAATATTAAAATATTCAATCAAGATATTTCAAAAAATAGAGATGAGATATTAATGCATGTAGGGGCATTAATTGAAGAACCTTCTTATTATAAAAATTTAACTGGTTTAGAAAATTTGCAAGTTATTCAAAGATTACTAAACTTACCTTCTAAAAATGTTAAAGAAGCTCTGAAAATTGTACGTTTAACTGAACACAAGGATAAATTAGTCAAAAATTATTCATTAGGTATGAAACAAAGGTTAGGTATTGCTTTAGCTATAGTAAAATTTCCAAAACTATTGATATTAGATGAACCTACTAACGGCTTAGATCCTTCTGGTATACAAGAAATTAGAGAATTAATAAAATCTTTTCCAAAAACTTATGGAATGACTGTACTTATATCTAGTCATTTATTATCTGAAATTGAACATATGGCTAATACAGTAGGTATCATCAATAGAGGGAAACTATTGTTTGAAGGAAAGTTAACAGAATTAGAAGAACAGAACAAAATATTGATAAATACTAACAATAACAGTGAGAGTATAAACTTGCTTCAATCAAAAGGATATAATCTAGAAAATAATGAAAAACCTCTCCTATTAGATACAACTCAAAAAGATATATCTACAGCCGTTAAATTGTTAGTTAATAATAAGTTCGAAATTTACCAAGTACAATCAGTTCAGAAAAGTTTAGAAGAAAATTTATAG	MINNIVQTQNLTKKFSDSYSVDNLSLNIGSKEIYGFLGPNGAGKSTTMKMLLGLMQPTKGNIKIFNQDISKNRDEILMHVGALIEEPSYYKNLTGLENLQVIQRLLNLPSKNVKEALKIVRLTEHKDKLVKNYSLGMKQRLGIALAIVKFPKLLILDEPTNGLDPSGIQEIRELIKSFPKTYGMTVLISSHLLSEIEHMANTVGIINRGKLLFEGKLTELEEQNKILINTNNNSESINLLQSKGYNLENNEKPLLLDTTQKDISTAVKLLVNNKFEIYQVQSVQKSLEENL	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG	95.10	gnl|BL_ORD_ID|315|hsp_num:0	345			0	675	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000539.1|Nukacin_7 # 7681 # 8433 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.255	BGC0000539.1|Nukacin_7 	7681	8433	+	Loose	1300	28.1054	mdtO	45.45	3003549	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTAAAAGCTATAAATTTAGAATTTTTCAAAATGCGGAGAAGAAAATTTATCCTTCCAATACTACTGATTACCTTTGTTGGTATATTGTGGTTTTGTGCTATAGCAATTAAAGAGTTAAATATTACTGATACAAAGTATGGTATTTATATGCTCATTTCTAATATTCTAACTATCGACAGCATGATTTATCCAATATTAATAGGTATTTTATGCTCAAGACTTGCAGATATAGAACATCAAGGAAAAACCTTTCAGTTATTAAATACTAGTAAACAAAGTGTTTTCAATTTGTTTACTAGTAAAGTTGGTGTTTCGCTTATTATTTTATTTGTAATTGACATTATACAATTAACGACCATCTTACTAATTGCTAATTCACATAATATCAGTTTGAAACTAGAAATCATTTCAAAATTCATGCTAAGTTTTATAATTGCTAGTTTCTTCTTAATATTAATTCATATGGCACTTTCTTTCTTTTTTGAAAAACAATCAGTTAGCATTGTATCAGCATTAGTAGGAAGTTTTTTAGGATTAGTAACAGGAGGGATGTTGCCTTCATATATTAAAATATTTTTGCCTTGGCAATATTATTCATTACTAAATCCAGTTCATAAAAAGATGGTTCACAAAGGATATGAATATTCAAATAATGACTATTATTTTATTTACATTTTTATTTCTATTCTAGTAATAGTAATTCTTTTCTTTATTATTAAAGCCTTAATAAAAAGGAGGGATTTAAATTGA	MLKAINLEFFKMRRRKFILPILLITFVGILWFCAIAIKELNITDTKYGIYMLISNILTIDSMIYPILIGILCSRLADIEHQGKTFQLLNTSKQSVFNLFTSKVGVSLIILFVIDIIQLTTILLIANSHNISLKLEIISKFMLSFIIASFFLILIHMALSFFFEKQSVSIVSALVGSFLGLVTGGMLPSYIKIFLPWQYYSLLNPVHKKMVHKGYEYSNNDYYFIYIFISILVIVILFFIIKALIKRRDLN	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ	36.60	gnl|BL_ORD_ID|1893|hsp_num:0	2056			495	561	acriflavine; puromycin
BGC0000539.1|Nukacin_8 # 8430 # 9167 # 1 # ID=1_8;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.260	BGC0000539.1|Nukacin_8 	8430	9167	+	Loose	300	24.6386	ThfT	21.54	3007427	protein homolog model	n/a	n/a	sulfonamide antibiotic	resistance by host-dependent nutrient acquisition	ECF transporter S component	TTGATTTCTTTATTAAGCATAGAATTACGCAAACTACAAAATAATTATATTTTAATCTTCTTATTAGTTTTTAATATATTAAGCGTATCTATAGGAAGTATGATATTTTATTTTAATCAAAGCGCTTTTCCTAATTCAAATAATAGAGATTTAATATTGTGGGGGCAAGAAACTTTATATACTTCACAACTTTTCTTTCCCATACTGATAGGTGTTTTATGTTCAATAAGTTGGCAATTTGAGGAGTCTAATAATAATTGGATGAGAATGAAAACTATACCTTTAAAAGAAAGTAAGATAGTTTTATCAAAATTTTTATCTCTTTTCTTACTTACTTTACTAAATCAAATTATATTTTTTGTATTATTTTGTATCTCAGCCTCAATAGTAAATGTATCCTTGGAAGGATTACTTAAATTTCTATACTGGGACTTTATAGGTTGGATAGGTACAGCATCTATTGTTGCTATACAATTATATTTGTCAGTTGCGACTAGAAATTTCACTTTCTCAATTTTAATATCAACTATTGGTGGTGTACTAGGTCTTCTAACATTGTTTATTAGCAATTTTATTTTTAAAATATTTCCATATTCACAAATTACAGTTGGTGTGAGAGCCAGATCTTTGATGAACTTCACTTTTTCAGAAATGTTACTTTTTCTTATAATAAATGTAGCTTATATAACAGTTTTTTTGACACTTACTACTTTAAAGCTTAAAAAAAGAGAGGGTTAA	MISLLSIELRKLQNNYILIFLLVFNILSVSIGSMIFYFNQSAFPNSNNRDLILWGQETLYTSQLFFPILIGVLCSISWQFEESNNNWMRMKTIPLKESKIVLSKFLSLFLLTLLNQIIFFVLFCISASIVNVSLEGLLKFLYWDFIGWIGTASIVAIQLYLSVATRNFTFSILISTIGGVLGLLTLFISNFIFKIFPYSQITVGVRARSLMNFTFSEMLLFLIINVAYITVFLTLTTLKLKKREG	MSPIFNGPKMSVQRLVSIAMLIALTLVISKFSIPVIPQQLVISFAFIGNTMIGMIAGPIWAFISLALVDVTDNLASGSGNFIIWWTLMEAVQGLLYGFFFYRKPLSTANKKDWLYVSLATIIIMLFGTFIFTPLLIQIYFHVPFWAQYAAGRWFKVFEIPLRVVITMLLVPALQRIPEIKKLNQA	132.43	gnl|BL_ORD_ID|4933|hsp_num:0	5926			291	486	sulfamethoxazole
BGC0000539.1|Nukacin_10 # 9561 # 9761 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.264	BGC0000539.1|Nukacin_10 	9561	9761	-	Loose	50	28.8758	vanY gene in vanA cluster	35.14	3002955	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanY; glycopeptide resistance gene cluster	ATGGCAGGATTTTTAGATGATATAGATACTTCGTCAGTTAAATATACTGAAAATTATAAACCTATTTCTAAAAGTACTACGATGCGTGTGGATACAAATTTAAAAAAACGTTTAAGTCAAATGGCATTAGATCAAGATACATCTATTAAAGCGATTGTTGATAATGTTTTAAATGAGTTTTTAGAAAAAAAAGGTTATTGA	MAGFLDDIDTSSVKYTENYKPISKSTTMRVDTNLKKRLSQMALDQDTSIKAIVDNVLNEFLEKKGY	MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR	21.78	gnl|BL_ORD_ID|4667|hsp_num:0	89			747	858	vancomycin; teicoplanin
